logo
episode-header-image
Sep 2
21m 26s

Call the shots: vaccine cuts imperil glo...

The Economist
About this episode

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newest supercomputer. And why Mexicans love Japanese and Korean culture. 


Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.


Hosted on Acast. See acast.com/privacy for more information.

Up next
Nov 21
Flee country: Britain seeks to slash migration
<p>Britain’s home secretary Shabana Mahmood proposed a big shift in <a href="https://www.economist.com/britain/2025/11/20/will-britain-copy-asylum-policy-from-a-place-with-poor-integration?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discov ... Show More
23m 22s
Nov 20
War graft: scandal engulfs Ukraine
<p>Pentagon officials are meeting President Volodymyr Zelensky in Kyiv to discuss a <a href="https://www.economist.com/europe/2025/11/19/a-terrible-american-russian-proposal-to-end-the-war-in-ukraine?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_con ... Show More
25m 24s
Nov 19
Crown prince arming: Trump sells jets to MBS
<p>Muhammad bin Salman’s <a href="https://www.economist.com/middle-east-and-africa/2025/11/18/saudi-arabia-is-in-no-hurry-to-join-the-abraham-accords?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-n ... Show More
21m 55s
Recommended Episodes
Sep 2
Call the shots: vaccine cuts imperil global health
America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ... Show More
21m 26s
Aug 2024
The human strain: can mpox be contained?
Mpox is spreading fast across Africa, yet public information campaigns are scant and vaccines in short supply. Is a new pandemic in the offing? Strategists are pondering a new potential threat from Russia: the possibility that it could detonate a nuclear weapon in space (09:42). ... Show More
25m 18s
Sep 18
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ... Show More
22m 31s
Apr 2025
Doomed traders: Trump’s tariff fallout
Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ... Show More
21m 20s
Oct 24
The great brawl: China is winning the trade war
This weekend American and Chinese officials are meeting to try and ease tensions over trade after China’s recent decision to restrict rare-earth exports. How has China gained the upper hand? Anxiety about screen time is focused on young people, but the elderly are addicted to dev ... Show More
23m 20s
Aug 29
WHO warns of growing cholera crisis
The World Health Organization says a resurgence of cholera in a number of African countries is putting more strain on already stretched health services. The WHO says more than 400,000 cases and nearly 5,000 deaths have been recorded worldwide this year, fuelled by conflict, pover ... Show More
26m 55s
Jan 2025
Putty people: can Trump get his picks?
As some of Donald Trump’s most controversial choices for top jobs are questioned this week, our correspondent analyses how supine Republicans may be in his second term. Has the luxury business passed its peak (09:57)? And why scientists are finding new ways to deal with an invasi ... Show More
23m 20s
Sep 19
Kimmel criticism, Nvidia-Intel, vaccines and France protests
The pulling of Jimmy Kimmel’s show has ignited a debate on free speech and drawn anger from both sides of the political aisle. Nvidia takes a $5 billion stake in Intel offering a new lifeline to the struggling chipmaker. A CDC panel votes against a combined MMRV shot for children ... Show More
12m 2s
Mar 2025
Conversation peace: can Europe bargain with Russia?
European leaders met in London this weekend after Donald Trump and Volodymyr Zelensky’s public row shattered hopes for a US-led truce in Ukraine. What did the summit achieve? Our correspondent visits Mexico’s border to find out if strengthened force will stem the flow of fentanyl ... Show More
24m 45s
Aug 18
Peace by piece? Zelensky and Trump meet again
After an inconclusive summit between Donald Trump and Vladimir Putin in Alaska on Friday, the stakes are high for Volodymyr Zelensky’s meeting with the US president in Washington today. Enter the “solopreneur”: why AI is allowing entrepreneurs to start and grow businesses on thei ... Show More
21m 6s